Profile data is unavailable for this security.
About the company
Pure Harvest Corporate Group, Inc. manufactures, distributes, and sells a range of cannabis products including hemp/ cannabidiol (CBD) and marijuana/ tetrahydrocannabinol (THC) consumer products. The Company's THC product line at its Dumont dispensary includes bulk flower, pre-rolls, and THC concentrates. The Company also sells THC distillate as an ingredient or raw material to other licensed marijuana infused products manufacturers within the State of Colorado along with wholesale THC concentrates, such as wax and shatter. It operates various segments of the cannabis and hemp- CBD industries with a focus on health and wellness products and applying education, research and development, and technology to each sector. It is also involved in the acquisition and operation of licensed marijuana cultivation facilities, manufacturing facilities, and dispensaries.
- Revenue in USD (TTM)2.48m
- Net income in USD-6.67m
- Incorporated2005
- Employees25.00
- LocationPure Harvest Corporate Group Inc7400 E. CRESTLINE CIRCLE, SUITE 130GREENWOOD VILLAGE 80111United StatesUSA
- Phone+1 (303) 674-2622
- Websitehttps://www.pureharvestgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Propanc Biopharma Inc | 0.00 | -2.46m | 226.77k | 1.00 | -- | -- | -- | -- | -0.3033 | -0.3033 | 0.00 | -0.0337 | 0.00 | -- | -- | -- | -2,440.90 | -4,945.87 | -- | -- | -- | -- | -- | -- | -- | -1.70 | -- | -- | -- | -- | -17.63 | -- | -- | -- |
| ContraFect Corp | 0.00 | -24.14m | 230.15k | 23.00 | -- | -- | -- | -- | -19.25 | -19.25 | 0.00 | -0.538 | 0.00 | -- | -- | 0.00 | -150.12 | -74.17 | -- | -94.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -221.24 | -- | -- | -- |
| CNBX Pharmaceuticals Inc | 540.25k | -1.23m | 245.78k | 2.00 | -- | -- | -- | 0.4549 | -0.0583 | -0.0583 | 0.0237 | -0.0758 | 1.73 | -- | -- | 270,125.00 | -393.70 | -73.32 | -- | -99.80 | 6.37 | -- | -228.08 | -3,970.88 | -- | -1.37 | -- | -- | -- | 111.90 | 0.3497 | -- | -- | -- |
| Limitless Venture Group Inc | 0.00 | -10.68m | 253.92k | -- | -- | -- | -- | -- | -117.82 | -117.82 | 0.00 | -9.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -37.95 | -- | -- | -- | -- | -- | -- | -- | -- |
| Bioquest Corp | 0.00 | -507.41k | 260.72k | -- | -- | -- | -- | -- | -0.0485 | -0.0485 | 0.00 | -0.0467 | 0.00 | -- | -- | -- | -3,483.76 | -- | -- | -- | -- | -- | -- | -- | -- | -3.88 | -- | -- | -- | -- | 64.67 | -- | -- | -- |
| Pure Harvest Corporate Group Inc | 2.48m | -6.67m | 290.19k | 25.00 | -- | 0.1911 | -- | 0.1172 | -0.0901 | -0.0901 | 0.0383 | 0.0201 | 0.2644 | 1.46 | 40.64 | 99,070.40 | -70.96 | -- | -136.76 | -- | 33.83 | -- | -268.37 | -- | 0.5886 | -0.866 | 0.7639 | -- | 1,808.41 | -- | -459.26 | -- | -- | -- |
| DMK Pharmaceuticals Corp | 3.62m | -21.16m | 295.99k | 11.00 | -- | -- | -- | 0.0818 | -8.69 | -9.18 | 1.04 | -0.4918 | 0.3432 | 5.66 | 5.54 | 329,062.70 | -200.59 | -79.00 | -- | -113.05 | -37.30 | 4.85 | -584.50 | -347.59 | 0.5355 | -- | -- | -- | 115.34 | -18.31 | 24.28 | -- | -20.10 | -- |
| Acorda Therapeutics Inc | 115.66m | -263.43m | 347.66k | 102.00 | -- | -- | -- | 0.003 | -212.10 | -212.10 | 93.13 | -149.56 | 0.5068 | 1.14 | 12.59 | 1,133,961.00 | -115.42 | -26.62 | -266.35 | -31.97 | 86.38 | 78.22 | -227.75 | -111.91 | 0.1533 | -0.692 | 33.57 | -- | -0.7869 | -24.24 | -283.60 | -- | -62.13 | -- |
| Baudax Bio Inc | 310.00k | -25.83m | 348.74k | 9.00 | -- | -- | -- | 1.12 | -17.25 | -9.17 | 0.0778 | -0.0985 | 0.0163 | -- | -- | 34,444.45 | -135.61 | -112.14 | -- | -192.87 | -1,445.81 | -- | -8,331.61 | -9,179.73 | -- | -- | 1.30 | -- | 17.50 | -- | -164.95 | -- | -56.52 | -- |
| NovAccess Global Inc | 0.00 | -1.74m | 356.82k | 1.00 | -- | -- | -- | -- | -0.1193 | -0.1193 | 0.00 | -0.2246 | 0.00 | -- | -- | 0.00 | -1,836.30 | -2,185.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -177.93 | -- | -- | -- |
| Drazcanna Inc | 2.05m | -5.71m | 359.18k | -- | -- | -- | -- | 0.1754 | -0.7024 | -0.7024 | 0.2492 | 0.1004 | 0.685 | -- | 23.88 | -- | -191.19 | -- | -643.20 | -- | -11.20 | -- | -279.10 | -- | -- | -33.04 | 0.2445 | -- | -- | -- | -- | -- | -- | -- |
